Scarica l'app Stockscreener
18.60
2.20%
0.40
Dopo l'orario di chiusura:
18.60
Precedente Chiudi:
$18.20
Aprire:
$18.9
Volume 24 ore:
29,117
Relative Volume:
2.50
Capitalizzazione di mercato:
$6.23B
Reddito:
$417.75M
Utile/perdita netta:
$32.27M
Rapporto P/E:
190.77
EPS:
0.0975
Flusso di cassa netto:
-
1 W Prestazione:
+1.97%
1M Prestazione:
+20.78%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$18.30
$19.19
Intervallo di 1 settimana:
$17.90
$19.20
Portata 52W:
$14.01
$19.20
Telix Pharmaceuticals Ltd Adr Stock (TLX) Company Profile
Nome
Telix Pharmaceuticals Ltd Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta TLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TLX
Telix Pharmaceuticals Ltd Adr
|
18.60 | 6.23B | 417.75M | 32.27M | 0 | 0.0975 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Telix Pharmaceuticals Ltd Adr Stock (TLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-15 | Iniziato | UBS | Buy |
Telix Pharmaceuticals Ltd Adr Borsa (TLX) Ultime notizie
Telix Pharmaceuticals acquires ImaginAb assets and technology - Investing.com
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform - GlobeNewswire Inc.
Telix Pharmaceuticals Hits Record $517M Revenue, Up 55% as Cancer Imaging Portfolio Expands - StockTitan
ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead
Health Check: ASX sleep company emerges from slumber with a revenue and earnings upgrade - Stockhead
UBS bullish on Telix stock—Illuccix growth & therapeutic expansion fuel upside - Investing.com
Telix Pharmaceuticals Debuts on Nasdaq Global Select Market Under TLX Symbol - StockTitan
Telix spins off radiopharma unit to form Rhine Pharma | Pharmaceutical | The Pharmaletter - The Pharma Letter
Guess which top 100 ASX stock is venturing off to the Nasdaq - The Motley Fool Australia
Telix Files Form 20-F Registration Statement for Nasdaq ADS - Yahoo Finance
Up 66% in FY24, will Telix Pharmaceuticals shares continue? - The Motley Fool Australia
TLX ASX: Telix pulls $300m Nasdaq IPO as investors demand deep discount - The Australian Financial Review
Pharmaceutical Industry Mergers & Acquisitions Roundup - Contract Pharma
Australia's Telix Pharmaceuticals jumps on potential US listing - Reuters.com
Check Up: These 4 ASX healthcare stocks come with Strong Buy recommendations - Stockhead
Queen's University Leads Irish Trial of New Prostate Cancer Treatment - Imaging Technology News
Telix Pharmaceuticals Ltd Adr Azioni (TLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.95%
2.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):